{"id":2071,"date":"2019-04-15T15:38:59","date_gmt":"2019-04-15T15:38:59","guid":{"rendered":"https:\/\/rhepa.se\/?p=2071"},"modified":"2021-05-12T08:20:33","modified_gmt":"2021-05-12T08:20:33","slug":"rhenman-partners-wins-prestigious-award-at-the-nordic-hedge-awards-best-performance-awards-for-5-years","status":"publish","type":"post","link":"https:\/\/rhepa.se\/en\/rhenman-partners-wins-prestigious-award-at-the-nordic-hedge-awards-best-performance-awards-for-5-years\/","title":{"rendered":"Rhenman &#038; Partners wins prestigious award at the Nordic Hedge Awards: Best Performance Awards for 5 Years"},"content":{"rendered":"<p>Since inception in June 2009, the fund has had annualised returns of +19%<br \/>\nThe sector fund Rhenman Healthcare Equity L\/S was named a winner at this year\u2019s Nordic<br \/>\nHedge Awards; best-performing Nordic hedge fund for five years. The award was made in<br \/>\nthe category &#8221;Performance Award for 60 Months&#8221;.<br \/>\n&#8221;We are tremendously pleased over this award. The Nordic Hedge Award is the most prestigious<br \/>\nNordic award for hedge funds and a total of 172 funds were evaluated in 2018. To put it simply,<br \/>\nthis is the Nordic championship and to win the category for the longest time period is a testament to<br \/>\nour unique investment process which leads the way, even internationally,&#8221; says Carl Grevelius, cofounder and head of investor relations.<br \/>\n&#8221;Our success depends largely on the many years of close collaboration between our fund managers<br \/>\nand the medical experts in our Scientific Advisory Board. Equally important is our investment team&#8217;s<br \/>\nsingle focus on the healthcare sector which includes pharmaceuticals, biotechnology, medical<br \/>\ntechnology and service. This sectoral focus probably gives us a knowledge advantage compared to<br \/>\nthose investors who monitor and invest in a number of sectors.\u201d<br \/>\nRhenman Healthcare Equity L\/S has an unprecedented performance history since its inception in<br \/>\nJune 2009. The main fund class, the IC1 (EUR), has increased by 449 percent in total, which<br \/>\ncorresponds to an average annual net return of 19 percent. In the first quarter 2019, the fund<br \/>\ndelivered a return of more than 15 percent. At present, assets under management in<br \/>\nthe fund exceed 600 million EUR.<br \/>\nFor further information, please contact:<br \/>\nCarl Grevelius, Founding Partner \/ Head of Investor Relations<br \/>\nPhone: +46 8 459 88 83<br \/>\nEmail: carl@rhepa.com<br \/>\nwww.rhepa.com<\/p>\n<p>About Rhenman &#038; Partners<br \/>\nRhenman &#038; Partners Asset Management, founded in 2008, is a Stockholm-based asset manager<br \/>\nfocusing on two niche funds: Rhenman Healthcare Equity L\/S, launched in June 2009,<br \/>\nand Rhenman Global Opportunities L\/S, launched in August 2016. Assets under<br \/>\nmanagement exceed 600 MEUR. The management teams of the two funds are supported in their<br \/>\nrespective investment processes by renowned advisors consisting of, among others,<br \/>\neminent professors and experts with many years of market experience and extensive expert<br \/>\nnetworks around the world<\/p>","protected":false},"excerpt":{"rendered":"<p>Since inception in June 2009, the fund has had annualised returns of +19% The sector fund Rhenman Healthcare Equity L\/S was named a winner at this year\u2019s Nordic Hedge Awards; best-performing Nordic hedge fund for five years. The award was made in the category &#8221;Performance Award for 60 Months&#8221;. &#8221;We are tremendously pleased over this [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-2071","post","type-post","status-publish","format-standard","hentry","category-rhenman-partners"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/posts\/2071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/comments?post=2071"}],"version-history":[{"count":1,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/posts\/2071\/revisions"}],"predecessor-version":[{"id":2072,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/posts\/2071\/revisions\/2072"}],"wp:attachment":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/media?parent=2071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/categories?post=2071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/tags?post=2071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}